Impax Laboratories (IPXL) Misses Q3 EPS by 2c

November 9, 2016 7:02 AM EST
Get Alerts IPXL Hot Sheet
Trade IPXL Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $228 million versus the consensus estimate of $234.87 million.

For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment